CNTX Context Therapeutics Inc
Company Analysis
Latest News
🟢 Context Therapeutics Inc Up 5.4% on Positive Interim Phase 1 CTIM-76 Data & Nasdaq Compliance
Context Therapeutics Inc is trading 5.4% higher at $1.46 in pre-market. This follows the announcement of positive interim Phase 1 clinical data for its CTIM-76...
🟢 Context Therapeutics Inc is trading 13.8% up today with no clear catalyst identified
Context Therapeutics Inc is trading at $1.73, up 13.8% in after-hours trading, with no clear fundamental catalyst identified to explain the price action. *...
🟢 Context Therapeutics Inc is trading 7.9% up today with no clear catalyst found
Context Therapeutics Inc is trading 7.9% up at $1.64 following the June 9 regular session close, despite a lack of company-specific news or announcements to...
🔴 Context Therapeutics Inc is trading 10.2% down today, extending a multi-day decline on weak momentum
Context Therapeutics Inc is trading 10.2% down today at $1.53, continuing a steep downward trend that has seen the stock fall from $2.85 on May 29, 2026. •...
🔴 Context Therapeutics Inc is trading 8.48% down today amid a multi-day slide and broader risk-off sentiment
Context Therapeutics Inc is trading 8.48% down at $1.56 today, extending a sharp multi-day decline amid weak momentum and broader risk-off sentiment in the...
🔴 Context Therapeutics Inc is trading 6.4% down today, extending a multi-day slide amid high volatility
Context Therapeutics Inc is trading 6.4% down today at $1.60, extending a sharp multi-day decline amid light newsflow and recent high volatility. • The move...
🔴 Context Therapeutics Inc is trading 11.4% down today amid a broad biotech selloff and hawkish rate expectations
Context Therapeutics Inc is trading 11.4% down at $2.00 following a sharp session decline driven by a broad market selloff rather than company-specific...
🔴 Context Therapeutics Inc is trading 10.84% down today amid broader market pressure and hawkish rate expectations
Context Therapeutics Inc is trading 10.84% down at $1.81 as broader market pressure weighs heavily on the biotechnology sector. • The move appears tied to a...
🔴 Context Therapeutics Inc is trading 5.2% down today amid broader biotech sector weakness
Context Therapeutics Inc is trading 5.2% down at $1.93 today as the stock continues a multi-day slide amid broader risk-off pressure hitting growth and...
🟢 Context Therapeutics Inc is trading 7.1% up today on a technical bounce after consecutive double-digit declines
Context Therapeutics Inc is trading up 7.1% at $2.19 as traders position for a short-term rebound following a period of heavy selling. • The move comes after...
🟢 Context Therapeutics Inc is trading 6.8% up today on a potential technical bounce after recent declines
Context Therapeutics Inc is trading 6.8% up today at $2.19 as the stock appears to be staging a technical bounce or attracting bargain hunters following two...
🔴 Context Therapeutics Inc is trading 10.9% down today as traders lock in profits after recent rally
Context Therapeutics Inc is trading 10.9% down at $2.48 as investors lock in gains following a sharp multi-day rally. • The stock recently surged from...
🔴 Context Therapeutics Inc is trading 6.3% down today as traders take profits following a multi-day rally
Context Therapeutics Inc is trading 6.3% down at $2.62 as the stock pulls back from a recent multi-day rally that saw prices rise from approximately $2.40. •...
🔴 Context Therapeutics Inc is trading 6.3% down today as it gives back recent gains
Context Therapeutics Inc is trading 6.3% down at $2.62 as the stock gives back a portion of its recent gains following a strong rally. • The decline follows a...